FABP1 and cardiovascular disorder: An altered mitochondrial β-oxidation was shown in early stages of normoalbuminuric diabetic kidney disease patients [36], and increased urinary levels of FABP1 suggested an increased incidence of progression of CKD and cardiovascular disease events [37,38].